ADC TOXICITY ATLAS
Payloads & linkers
Payload · Auristatin

Auristatin F-hydroxypropylamide (AF-HPA; ledadotin; DolaLock/Dolasynthen payload)

Microtubule polymerization inhibitor; AF-HPA is membrane-permeable and is intracellularly converted to the membrane-impermeable active catabolite auristatin F (controlled bystander effect)

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NCCCO)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C
Physicochemistry

Properties

MW
803.1 Da
XLogP3
4.3
logD₇.₄
-
TPSA
170 Ų
pKa
-
Charge pH 7.4
0
H-bond donors
4
H-bond acceptors
9
Bystander
Partial
PubChem CID
71135741
1 agent

ADCs built on this payload

Agent · target
Ocular
Hepatic
Neutrop.
Thrombo.
Anemia
GI
ILD
Neuro.
XMT-1660 (Emiltatug ledadotin)VTCN1
0
38
0
0
29
0
0
0%severity100%
0
Assessed · clear
true 0%
No data
never assessed